ADRB2 and type 2 diabetes mellitus: This mechanism provides a potential explanation for the harmful effects of intensive insulin treatment observed in T2D patients, suggesting GRK2 and β2AR as potential promising pharmacological targets for the treatment of cardiomyopathy in T2D.